Zacks.com featured highlights include Roku, Universal Health Services and Atlassian

By Zacks Equity Research | November 06, 2025, 4:01 AM

For Immediate Release

Chicago, IL – November 6, 2025 – Stocks in this week’s article are — like Roku, Inc. ROKU, Universal Health Services, Inc. UHS, Atlassian Corp. TEAM.

Buy These 3 Stocks with Upgraded Broker Ratings Right Now

Investor sentiments have been bullish of late on the back of solid third-quarter earnings performance. While the government shutdown and resulting blackout of economic data are concerns, investors seem to be optimistic about the overall health of the economy. In September, the Federal Reserve lowered interest rates amid a continued deterioration in the labor market. Amid such a backdrop, retail investors face massive challenges in picking the right stocks and generating robust returns.

One way to cut short this task is to follow brokers’ recommendations. In this regard, stocks such as Roku, Inc., Universal Health Services, Inc. and Atlassian Corp. are worth considering for investment.

Brokers gain valuable insights into companies through direct engagement with senior management, analysis of public disclosures and participation in earnings calls. Their broad sector perspective enables them to assess a company’s fundamentals within the wider economic landscape, offering a more informed view of potential stock performance.

However, while a broker’s upgrade can be a helpful signal, it should not be the sole basis for investment decisions. Achieving sustainable, long-term returns requires investors to consider a comprehensive set of factors beyond broker recommendations.

3 Stocks with Upgraded Broker Ratings to Bet On

San Jose, CA-based Roku is the leading TV streaming platform provider in the United States, Canada and Mexico based on hours streamed. It operates through two reportable segments: Platform and Devices.

Roku’s 2025 earnings are expected to soar 134.8% year over year. ROKU, which currently carries a Zacks Rank #2, has witnessed a 6.7% upward revision in broker ratings over the past four weeks.

Universal Health Services, based in King of Prussia, PA, owns and operates (through its subsidiaries) acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. UHS, through its subsidiaries, operates more than 355 inpatient acute care hospitals and 60 outpatient and other facilities located in 39 states, Washington, DC, the United Kingdom and Puerto Rico.

Its 2025 earnings are projected to surge 27.6% on a year-over-year basis. Universal Health Services, sporting a Zacks Rank #1 at present, has witnessed 5% upward revision in broker ratings over the past four weeks.

Based in Sydney, Australia, Atlassian is a global leader and innovator in the enterprise collaboration and workflow software space. TEAM offers a suite of cloud-based software solutions that help organizations collaborate and manage their workforce, such that the teams work better together.

Its fiscal 2026 earnings are expected to rise 16.3% year over year. TEAM, currently carrying a Zacks Rank #2, has witnessed a 3.6% upward revision in broker ratings over the past four weeks.

Get the remaining stock on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial of the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at:

https://www.zacks.com/stock/news/2785485/buy-these-3-stocks-with-upgraded-broker-ratings-right-now

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: [email protected]

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Universal Health Services, Inc. (UHS): Free Stock Analysis Report
 
Atlassian Corporation PLC (TEAM): Free Stock Analysis Report
 
Roku, Inc. (ROKU): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News